MARKETRESEARCH
Uploaded on Mar 28, 2024
Category
Business
According to the latest research report by IMARC Group, The global ureteral stents market size reached US$ 374.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 606.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. More Info:- https://www.imarcgroup.com/ureteral-stents-market
Category
Business
Ureteral Stents Market PPT: Overview, Dynamics, Trends, Segmentation, Application and Forecast to 2032
Global Ureteral Stents
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved
About IMARC Group
In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management
s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry
vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and
t ransform thei r bus inesses.
IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological
developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology
organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls ,
chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods
are at the top of the company’s exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and
markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients
achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure
las t ing resul ts .
Accord ing t o the la tes t r epo r t by IMARC Group, t i t l ed "Uretera l S ten ts Market :
G loba l I ndust ry T rends , Share , S ize , Grow th , Opportun i ty and Forecast 2024-
2032, " t he g loba l u re t e ra l s ten t s marke t s i ze reached US$ 374 .9 M i l l i on in 2023 .
Ure te ra l s ten ts re fe r t o f l ex ib le , t h i n , and ho l low p las t i c t ubes p laced ins ide the
Report ure t e r t o a l low u r ine t o pass f r om the k idney in to t he b ladder . They l i ne t he en t i r e
leng th o f t he u re t e r t o keep i t open. Wh i le t he t op pa r t o f t he s t en t has a co i l t ha t
Highlight and s i t s in t he k idney , t he loop a t t he lower end s i t s ins ide the b ladder . They he lp res t o re u r ine f l ow th rough the b locked u re te r , l ower t he pa in
assoc ia ted w i th the b lockage , and enab le the k idney t o f unc t ion no rma l l y . As a
Description resu l t , u re t e ra l s t en ts a re w ide l y used t o m anage and t rea t var ious cond i t i ons ,
such as k idney s t ones , k idney t ransp lan t s , u r i na ry incon t i nence , p ros ta te cancer ,
and t umors .
Request fo r a PDF sample o f th is repor t :
ht tps : / / www. imarcgroup .com/u re t e ra l - s ten t s -marke t / reques t samp le
Report Description
G l o b a l U r e t e r a l S t e n t s M a r k e t T r e n d s :
U r e t e r a l s t e n t s a r e e x t e n s i v e l y u t i l i z e d d u r i n g t h e p r o c e d u r e o f u r e t e r o s c o p y a n d u r e t e r o r e n o s c o p y . C o n s e q u e n t l y , t h e r i s i n g
i n c i d e n c e s o f u r o l o g i c a l a n d k i d n e y d i s o r d e r s r e p r e s e n t t h e p r i m a r y f a c t o r d r i v i n g t h e m a r k e t g r o w t h . T h i s c a n b e a t t r i b u t e d t o t h e h i g h
q u a n t i t y o f c a l c i u m i n t h e d i e t , g r o w i n g a l c o h o l c o n s u m p t i o n , a n d u n h e a l t h y l i f e s t y l e h a b i t s o f i n d i v i d u a l s . M o r e o v e r , t h e s u r g i n g c a s e s
o f p r o s t a t e c a n c e r , t u m o r s , a n d n a r r o w i n g o r s c a r r i n g o f t h e u r e t e r h a v e a u g m e n t e d t h e p r o d u c t d e m a n d . I n a d d i t i o n , t h e r e h a s b e e n a
r i s e i n t h e u s e o f u r e t e r a l s t e n t s d u r i n g k i d n e y t r a n s p l a n t s , w h e r e i n t h e y a r e p l a c e d i n s i d e t h e p a t i e n t ’ s b o d y u n t i l t h e n e w l y i m p l a n t e d
k i d n e y a d a p t s t o t h e b o d y . A l o n g w i t h t h i s , t h e i n c r e a s i n g n u m b e r o f r e n a l t r a n s p l a n t s a n d t h e g r o w i n g c o n c e r n s r e l a t e d t o r e n a l
d y s f u n c t i o n h a v e c a t a l y z e d m a r k e t g r o w t h . F u r t h e r m o r e , t h e l e a d i n g p l a y e r s a r e f o c u s i n g o n l a u n c h i n g i n n o v a t i v e p r o d u c t v a r i a n t s t h a t
r e d u c e s t e n t m i g r a t i o n , u r e t e r o v e s i c a l r e f l u x , a n d t i s s u e i r r i t a t i o n d u r i n g t h e p r o c e d u r e . I n l i n e w i t h t h i s , t h e r i s i n g a d o p t i o n o f
b i o d e g r a d a b l e m a t e r i a l s w i t h a n t i b a c t e r i a l c o a t i n g s f o r e f f i c i e n t a n d i m p r o v e d r e s u l t s r e l a t e d t o u r i n a r y a n d k i d n e y d i s o r d e r s h a s
p r o p e l l e d m a r k e t g r o w t h . O t h e r f a c t o r s , i n c l u d i n g t h e i n c r e a s i n g r e g u l a t o r y a p p r o v a l s f o r p o l y m e r - b a s e d u r e t e r a l s t e n t s , f a v o r a b l e
r e i m b u r s e m e n t p o l i c i e s , i m p r o v i n g h e a l t h c a r e i n f r a s t r u c t u r e , a n d t e c h n o l o g i c a l i n n o v a t i o n s , a r e c r e a t i n g a p o s i t i v e m a r k e t o u t l o o k .
L o o k i n g f o r w a r d , I M A R C G r o u p e x p e c t s t h e m a r k e t v a l u e t o r e a c h U S $ 6 0 6 . 5 M i l l i o n b y 2 0 3 2 , g r o w i n g a t a C A G R o f 5 . 3 % d u r i n g
2 0 2 4 - 2 0 3 2 .
V i e w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / u r e t e r a l - s t e n t s - m a r k e t
Breakup by Product Type:
• Open End Stents
• Closed End Stents
• Double J-Stent
• Mult i loop Stents
Breakup by Material:
Report • Metal l ic Ureteral Stents
Segmentation • Polymer Ureteral Stents
o Si l icone Stents
o Polyurethane Stents
o Hybrid Stents
Breakup by Application:
• Kidney Stones
• Kidney Transplantat ion
• Tumors
• Urinary Incontinence
• Others
Breakup by End Use:
• Hospitals and Cl inics
Report • Ambulatory Surgical Centers (ASCs)
• Others
Segmentation
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• All ium Medical Solutions Ltd.
• B. Braun Melsungen AG
• Biomerics
Competitive • Boston Scient ifi c Corporation
Landscape • Becton, Dickinson and Company
• Coloplast Ltd.
with Key
• Cook Group Incorporated
Players • Medline Industries Inc.
• Merit Medical Systems Inc.
• Olympus Corporation
• Telefl ex Incorporated
What was the size of the global ureteral stents
market in 2023?
What is the expected growth rate of the global
ureteral stents market during 2024-2032?
Key
What has been the impact of COVID-19 on the
global ureteral stents market?
Questions
Answered in What are the key factors driving the global ureteral
stents market?
the Report
What is the breakup of the global ureteral stents
market based on the product type?
What is the breakup of the global ureteral stents
market based on the material?
What is the breakup of the global ureteral stents
market based on the application?
What is the breakup of the global ureteral stents
market based on the end use?
Key
Questions What are the key regions in the global ureteral stents market?
Answered in
Who are the key players/companies in the global
the Report ureteral stents market?
1 P r e f a c e
2 S c o p e a n d M e t h o d o l o g y
2 . 1 O b j e c t i v e s o f t h e S t u d y
2 . 2 S t a k e h o l d e r s
2 . 3 D a t a S o u r c e s
2 . 3 . 1 P r i m a r y S o u r c e s
2 . 3 . 2 S e c o n d a r y S o u r c e s
2 . 4 M a r k e t E s t i m a t i o n
Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h
2 . 5 F o r e c a s t i n g M e t h o d o l o g y
3 E x e c u t i v e S u m m a r y
4 I n t r o d u c t i o n
Contents 4 . 1 O v e r v i e w 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l U r e t e r a l S t e n t s M a r k e t
5 . 1 M a r k e t O v e r v i e w
5 . 2 M a r k e t P e r f o r m a n c e
5 . 3 I m p a c t o f C O V I D - 1 9
5 . 4 M a r k e t F o r e c a s t
6 M a r k e t B r e a k u p b y P r o d u c t T y p e
6 . 1 O p e n E n d S t e n t s
6 . 1 . 1 M a r k e t T r e n d s
6 . 1 . 2 M a r k e t F o r e c a s t
6 . 2 C l o s e d E n d S t e n t s
6 . 2 . 1 M a r k e t T r e n d s
6 . 2 . 2 M a r k e t F o r e c a s t
6 . 3 D o u b l e J - S t e n t s
6 . 3 . 1 M a r k e t T r e n d s
6 . 3 . 2 M a r k e t F o r e c a s t
6 . 4 M u l t i l o o p S t e n t s
6 . 4 . 1 M a r k e t T r e n d s
6 . 4 . 2 M a r k e t F o r e c a s t
7 M a r k e t B r e a k u p b y M a t e r i a l
7 . 1 M e t a l l i c U r e t e r a l S t e n t s
7 . 1 . 1 M a r k e t T r e n d s
7 . 1 . 2 M a r k e t F o r e c a s t
7 . 2 P o l y m e r U r e t e r a l S t e n t s
7 . 2 . 1 M a r k e t T r e n d s
7 . 2 . 2 M a j o r T y p e s
7 . 2 . 2 . 1 S i l i c o n e S t e n t s
7 . 2 . 2 . 2 P o l y u r e t h a n e S t e n t s
Table of 7 . 2 . 2 . 3 H y b r i d S t e n t s
7 . 2 . 3 M a r k e t F o r e c a s t
8 M a r k e t B r e a k u p b y A p p l i c a t i o n
Contents 8 . 1 K i d n e y S t o n e s 8 . 1 . 1 M a r k e t T r e n d s
8 . 1 . 2 M a r k e t F o r e c a s t
8 . 2 K i d n e y T r a n s p l a n t a t i o n
8 . 2 . 1 M a r k e t T r e n d s
8 . 2 . 2 M a r k e t F o r e c a s t
8 . 3 T u m o r s
8 . 3 . 1 M a r k e t T r e n d s
8 . 3 . 2 M a r k e t F o r e c a s t
8 . 4 U r i n a r y I n c o n t i n e n c e
8 . 4 . 1 M a r k e t T r e n d s
8 . 4 . 2 M a r k e t F o r e c a s t
8 . 5 O t h e r s
8 . 5 . 1 M a r k e t T r e n d s
8 . 5 . 2 M a r k e t F o r e c a s t
F o r m o r e i n f o r m a t i o n , v i s i t :
h t t p s : / / w w w. im a rcg ro u p . co m / u re t e r a l - s t en t s - m a r ke t / t o c
Disclaimer
© 2023 IMARC Al l R ights Reserved
Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f
I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be
rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so
no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing ,
reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress
c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) .
Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion
have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f
pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f
war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC
accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r
i naccu rac ies i f any f ound th is pub l i ca t ion .
IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l
Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re
reg i s te red t rademarks o f t he i r r espec t i ve compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: [email protected]
Comments